In Case You Missed Them 2025: The UAE’s Key Healthcare Developments in 2025

6 min 17 sec February 6, 2026 (Edited)

Written by

Clive DSouza

Associate

c.dsouza@tamimi.com View LinkedIn Profile

The UAE’s healthcare regulatory landscape continued to evolve at pace throughout 2025, reflecting the state’s sustained commitment to patient safety, clinical quality, regulatory oversight, and sector resilience. Federal and emirate-level authorities issued a broad range of legislative and regulatory instruments affecting healthcare facilities, professionals, medical products, public health, and emerging areas of healthcare innovation.

For healthcare providers, facility operators, pharmaceutical and life sciences companies, investors, and in-house legal and compliance teams, 2025 marked a shift toward greater regulatory specificity. Authorities increasingly relied on detailed national standards, clearer governance frameworks, and enhanced digital oversight to close regulatory gaps and strengthen compliance expectations.

This article summarises the most significant healthcare-related legislative developments issued in 2025, arranged by regulatory and operational priority, to assist stakeholders in assessing their compliance, governance, and strategic impact.

Regulation of healthcare facilities and clinical services

The regulation of healthcare facilities and clinical services remained the primary compliance focus for healthcare operators in 2025. The Resolution of the Ministry of Health and Prevention No. (79) of 2025 on the Types and Classification of Private Health Facilities and their Scope of Activities introduced a more structured federal framework governing facility classification, permissible services, and licensing alignment. The Resolution reduces ambiguity by linking licensed activities to defined facility categories and reinforcing alignment between scope of practice, staffing, and infrastructure.

Facility-specific regulation was further strengthened through the Resolution of the Ministry of Health and Prevention No. (99) of 2025 Approving the National Standards for Long-Term Healthcare Facilities, which imposes enhanced obligations relating to governance, staffing ratios, infection prevention, patient rights, and quality management systems. These standards reflect heightened regulatory scrutiny of long-term and post-acute care services due to patient vulnerability.

The Ministry also expanded oversight to decentralised and ancillary care models. The Resolution of the Minister of Health and Prevention No. (183) of 2025 Approving the National Standards for Mobile Healthcare Units and the Resolution No. (175) of 2025 Approving the National Standards for First Aid Units establish uniform licensing, operational, and governance requirements for mobile clinics and first aid services. In parallel, specialised services were addressed through national standards for hair transplant services, sleep laboratory units, and laser vision correction operations, reinforcing patient safety and clinical governance.

Health research, innovation, and integrative medicine

Future-focused regulation featured prominently in 2025, reflecting the UAE’s strategic emphasis on innovation and research-driven healthcare. The Minister of Health and Prevention Resolution No. (144) of 2025 Approving the Future Foresight Strategy of Health Research in the United Arab Emirates sets long-term priorities for health research. These include predictive and preventive care, health data analytics, translational research, and collaboration between healthcare providers, academic institutions, and the private sector.

The Strategy signals increasing regulatory support for clinical research, innovation partnerships, and advanced healthcare technologies, while also reinforcing expectations around ethical governance, data protection, and research integrity. Healthcare operators and corporate stakeholders should expect closer alignment between regulatory policy and national research objectives.

In parallel, the Cabinet Resolution No. (105) of 2025 Establishing the UAE Council for Integrative Medicine formalises governance of complementary and integrative healthcare practices. The Council is mandated to develop policies and standards governing the safe integration of such practices into mainstream healthcare delivery, providing long-awaited regulatory clarity while reinforcing professional and ethical boundaries.

International health cooperation

International cooperation in the health sector was strengthened through the Federal Decree No. (14) of 2025 Ratifying the Agreement between the Government of the United Arab Emirates and the World Health Organization on the Establishment of the WHO Hub for Global Health Emergencies Logistics. The agreement reinforces the UAE’s role as a global hub for health emergency preparedness and logistics coordination.

From an operational perspective, this development underscores the UAE’s growing engagement with global health governance frameworks and may have downstream implications for healthcare logistics providers, emergency planning, and cross-border coordination during health crises.

Healthcare professionals, scope of practice, and clinical governance

The regulation of healthcare professionals and clinical decision-making structures remained a key priority in 2025. The Resolution of the Minister of Health and Prevention No. (146) of 2025 Approving the National Scope of Practice for Assistant Practitioners clarifies permissible activities, supervision requirements, and professional boundaries, supporting workforce optimisation while maintaining patient safety.

Professional classifications were further refined through the Minister of Health and Prevention Resolution No. (37) of 2025 Replacing Annex No. (4) Attached to Ministerial Resolution No. (150) of 2024, aligning regulatory expectations with evolving clinical practice models and service delivery needs.

Clinical governance mechanisms were also strengthened through the Resolution of the Minister of Health and Community Protection No. (20) of 2025 on multidisciplinary medical committees for cancer case evaluation, and the Resolution No. (185) of 2025 governing the Birth and Death Committee, reinforcing structured oversight, accountability, and data integrity.

Public health, preventive care, and population health

Public health regulation featured prominently in 2025, particularly at the emirate level. The Law No. (5) of 2025 Concerning Public Health in the Emirate of Dubai represents a comprehensive overhaul of Dubai’s public health framework, introducing obligations relating to disease prevention, environmental health, food safety, occupational health, and emergency preparedness.

Enforcement mechanisms were clarified through the Resolution No. (35) of 2025 Concerning the Fees, Violations and Fines Stipulated in Law No. (5) of 2025, signalling a stricter compliance environment with potentially significant financial penalties for breaches.

At the federal level, preventive care was reinforced through the Minister of Health and Prevention Resolution No. (155) of 2025 Regarding Newborn Medical Examination, while the Cabinet Resolution No. (4) of 2025 revised fees for expatriate medical examinations, further aligning immigration processes with public and occupational health objectives.

Medical products, pharmaceuticals, and drug regulation

Pharmaceutical regulation remained active in 2025 under the oversight of the Emirates Drug Establishment (EDE). The Cabinet Resolution No. (40) of 2025 Regarding the Service Fees Provided by the Emirates Drug Establishment revised fee structures affecting product registration, licensing, importation, and post-approval activities.

This was accompanied by a series of EDE pricing resolutions, including Resolutions Nos. (22), (23), (37), (38), (43), (44), (49), and (52) of 2025, reinforcing price transparency, affordability objectives, and market oversight. Product availability and safety were further supported by the updated National Essential Medicines List approved under Resolution No. (47) of 2025.

Additional controls were introduced through language requirements for package inserts under Resolution No. (57) of 2025, amendments to chemical precursor lists under Resolution No. (50) of 2025, and regulation of veterinary medicines and vaccines, reflecting the interconnected nature of public health and product regulation.

Controlled medicines and digital prescribing

Oversight of controlled medicines was significantly strengthened through the Minister of Climate Change and Environment Resolution No. (240) of 2025 Regarding Mandatory Registration with the Unified Platform for the Prescription and Dispensing of Narcotic, Controlled and Semi-Controlled Drugs. The Resolution mandates compulsory registration and use of a unified electronic platform for prescribing and dispensing controlled substances.

The platform enables end-to-end traceability of controlled medicines, enhances regulatory visibility, and allows authorities to monitor prescribing patterns and identify misuse or diversion risks in real time. This aligns the UAE with international best practices in electronic prescription monitoring.

Healthcare providers and pharmacies must ensure systems integration, staff training, and strict adherence to platform requirements. Controlled medicines compliance is now a heightened governance risk, with increased potential for regulatory scrutiny and enforcement.

Organ donation, transplantation, and bioethics

Bioethical regulation was refined through the Federal Decree-Law No. (15) of 2025 Amending Certain Provisions of Federal Decree-Law No. (25) of 2023 Regarding Donation and Transplantation of Human Organs and Tissues. The amendments strengthen informed consent requirements and clarify institutional responsibilities.

The updated framework reinforces governance and oversight obligations for licensed transplant centres, including adherence to approved protocols, reporting requirements, and ethical review processes. These measures are designed to prevent unethical practices and protect donor and recipient rights.

Healthcare institutions involved in transplantation activities must review consent documentation, governance arrangements, and compliance procedures to ensure alignment with the amended law, given the heightened regulatory and ethical scrutiny in this area.